These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6480046)

  • 1. Nitroso derivatives of harman and norharman--their formation, characterization and mutagenicity.
    Nagalakshmi C; Subbaraman AS; Pednekar MD; Choughuley AS
    Indian J Exp Biol; 1984 Feb; 22(2):84-7. PubMed ID: 6480046
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of norharman on the mutagenicity of toluidine metabolites.
    Gupta RL; Kaur IP; Gupta AK; Pathak DP; Juneja TR
    Toxicol Lett; 1989 Jul; 48(1):75-81. PubMed ID: 2665189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harman and norharman induce SOS responses and frameshift mutations in bacteria.
    Oda Y; Nakamura S; Oki I
    Mutat Res; 1988 May; 208(1):39-44. PubMed ID: 3285203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comutagenic effect of norharman and harman with 2-acetylaminofluorene derivatives.
    Umezawa K; Shirai A; Matsushima T; Sugimura T
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):928-30. PubMed ID: 345280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorination of harman and norharman with sodium hypochlorite and co-mutagenicity of the chlorinated products.
    Nakano K; Suyama K; Fukazawa H; Uchida M; Wakabayashi K; Shiozawa T; Terao Y
    Mutat Res; 2000 Oct; 470(2):141-6. PubMed ID: 11027968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comutagenic effect of norharman with aminopyridine derivatives.
    Wakabayashi K; Yahagi T; Nagao M; Sugimura T
    Mutat Res; 1982 Oct; 105(4):205-10. PubMed ID: 7133029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-mutagenic effect of norharman with N-nitrosamine derivatives.
    Wakabayashi K; Nagao M; Kawachi T; Sugimura T
    Mutat Res; 1981 Jan; 80(1):1-7. PubMed ID: 7010130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of appearance of mutagenicity of N-nitrosodiphenylamine with norharman.
    Wakabayashi K; Nagao M; Kawachi T; Sugimura T
    IARC Sci Publ; 1982; (41):695-707. PubMed ID: 7141576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenic activity of norharman and harman in Chinese hamster lung cells in assays with diphtheria toxin resistance as a marker.
    Nakayasu M; Nakasato F; Sakamoto H; Terada M; Sugimura T
    Cancer Lett; 1983 Jan; 17(3):249-55. PubMed ID: 6831382
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of harman and norharman on the mutagenicity and binding to DNA of benzo[a]pyrene metabolites in vitro and on aryl hydrocarbon hydroxylase induction in cell culture.
    Levitt RC; Legraverend C; Nebert DW; Pelkonen O
    Biochem Biophys Res Commun; 1977 Dec; 79(4):1167-75. PubMed ID: 603652
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of comutagenicity by norharman and other compounds on revertants induced by photolabeling with 2-azido-9-fluorenone oxime.
    White WE; Rock SG
    Mutat Res; 1981 Dec; 84(2):263-71. PubMed ID: 7038453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A screening procedure for the formation of nitroso derivatives and mutagens by drug-nitrite interaction.
    Takeda Y; Kanaya H
    Chem Pharm Bull (Tokyo); 1982 Sep; 30(9):3399-404. PubMed ID: 6756658
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotransformation of tryptophan by Phaseolus vulgaris suspension culture.
    Veliky IA; Barber KM
    Lloydia; 1975; 38(2):125-30. PubMed ID: 1134210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation, deoxygenation and mutagenicity of alpha-hydroperoxydialkylnitrosamines.
    Okada M; Mochizuki M; Anjo T; Sone T; Wakabayashi Y; Suzuki E
    IARC Sci Publ; 1980; (31):71-82. PubMed ID: 7014439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotoxic potential of beta-carbolines: a review.
    de Meester C
    Mutat Res; 1995 Oct; 339(3):139-53. PubMed ID: 7491124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in effects of norharman with various classes of chemical mutagens and amounts of S-9.
    Nagao M; Yahagi T; Sugimura T
    Biochem Biophys Res Commun; 1978 Jul; 83(2):373-8. PubMed ID: 358980
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mutagenic activity of chlorodimethylsulfide and some of its aniline derivatives].
    Vito M; Esposito G; Vicari L; Lembo S; Imperatrice ML; De Marinis E
    Boll Soc Ital Biol Sper; 1985 Jun; 61(6):917-23. PubMed ID: 4052257
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma harman and norharman in Parkinson's disease.
    Kuhn W; Müller T; Grosse H; Rommelspacher H
    J Neural Transm Suppl; 1995; 46():291-5. PubMed ID: 8821066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA adducts formed by the comutagens harman and norharman in various tissues of mice.
    Yamashita K; Ohgaki H; Wakabayashi K; Nagao M; Sugimura T
    Cancer Lett; 1988 Nov; 42(3):179-83. PubMed ID: 3191469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mutagenic action of foreign substances contained in food products].
    Maganova NB
    Vopr Pitan; 1982; (2):3-8. PubMed ID: 7046245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.